Myriad Genetics to Present at the 2013 J.P. Morgan Annual Healthcare Conference

[at noodls] – December 17, 2012 SALT LAKE CITY, Dec. 17, 2012 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that Peter D. Meldrum, President and CEO, is scheduled to present at the 2013 J.P. … more

View todays social media effects on MYGN

View the latest stocks trending across Twitter. Click to view dashboard

See who Myriad is hiring next, click here to view